Study of BGB-A425 and LBL-007 in Combination With Tislelizumab in Advanced Solid Tumors | BeOne Medicines

Study of BGB-A425 and LBL-007 in Combination With Tislelizumab in Advanced Solid Tumors

Beigene Study ID

BGB-900-102

ClinicalTrials.gov ID

NCT03744468

EudraCT Number

2022-500694-14

Study Overview

Sex: All

Age: 18 Years / N/A

Accepts Healthy Volunteers? yes

No Study Documents

Study Overview

Sex: All

Age: 18 Years / N/A

Accepts Healthy Volunteers? yes

No Study Documents